Peter Lange

Peter Lange

No job title VIP


  1. Published

    C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

    Dahl, M., Vestbo, J., Lange, Peter, Bojesen, Stig Egil, Tybjærg-Hansen, Anne & Nordestgaard, Børge, 2007, In: American Journal of Respiratory and Critical Care Medicine. 175, 3, p. 250-5 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study

    Dahl, M., Tybjærg-Hansen, Anne, Lange, Peter & Nordestgaard, Børge, 2005, In: Respiratory Research. 6, p. 113

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

    Dahl, Morten, Vestbo, J., Lange, Peter, Bojesen, Stig Egil, Tybjærg-Hansen, Anne & Nordestgaard, B. G., 1 Feb 2007, In: American Journal of Respiratory and Critical Care Medicine. 175, 3, p. 250-255

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma

    Dahl, M., Tybjærg-Hansen, Anne, Lange, Peter & Nordestgaard, Børge, 27 Jun 1998, In: Lancet. 351, 9120, p. 1911-3 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population

    Dahl, M., Tybjærg-Hansen, Anne, Lange, Peter, Vestbo, J. & Nordestgaard, Børge, 19 Feb 2002, In: Annals of Internal Medicine. 136, 4, p. 270-9 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial

    Day, N. C., Kumar, S., Criner, G., Dransfield, M., Halpin, D. M. G., Han, M. K., Jones, C. E., Kaisermann, M. C., Kilbride, S., Lange, Peter, Lomas, D. A., Martin, N., Martinez, F. J., Singh, D., Wise, R. & Lipson, D. A., 2020, In: Respiratory research. 21, 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT

    Dransfield, M. T., Crim, C., Criner, G. J., Day, N. C., Halpin, D. M. G., Han, M. K., Jones, C. E., Kilbride, S., LaFon, D., Lipson, D. A., Lomas, D. A., Martin, N., Martinez, F. J., Singh, D., Wise, R. A. & Lange, Peter, 2021, In: Annals of the American Thoracic Society. 18, 5, p. 788-798 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial

    Dransfield, M. T., Criner, G. J., Halpin, D. M. G., Han, M. K., Hartley, B., Kalhan, R., Lange, Peter, Lipson, D. A., Martinez, F. J., Midwinter, D., Singh, D., Wise, R. & Kunisaki, K. M., 2022, In: Journal of the American Heart Association. 11, 18, e024350.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Exhaled CO, a predictor of lung function?

    Fabricius, P., Scharling, H., Lokke, A., Vestbo, J. & Lange, Peter, 2007, In: Respiratory Medicine. 101, 3, p. 581-6 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Diet and lung cancer.

    Fabricius, P. & Lange, Peter, 2003, In: Monaldi Archives for Chest Disease. 59, 3, p. 207-211 5 p.

    Research output: Contribution to journalReviewResearch

Previous 1...3 4 5 6 7 8 9 10 ...32 Next

ID: 33970784